Wiley, R G <br/><br/>
Destruction of the cholinergic basal forebrain using immunotoxin to rat NGF receptor: modeling the cholinergic degeneration of Alzheimer's disease.  [electronic resource] 

 -  Journal of the neurological sciences  Feb 1995 
 - 157-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-510X 
<br/><br/><label>Standard No.: </label>10.1016/0022-510x(94)00226-e  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease<br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Avoidance Learning--physiology<br/>Basal Ganglia--drug effects<br/>Behavior, Animal--physiology<br/>Cell Count<br/>Cells, Cultured<br/>Cholinergic Fibers--drug effects<br/>Disease Models, Animal<br/>Ganglia, Sympathetic--cytology<br/>Humans<br/>Immunoconjugates<br/>Immunoglobulin G--immunology<br/>Immunotoxins--administration & dosage<br/>Injections, Intraventricular<br/>Learning Disabilities--chemically induced<br/>Male<br/>Membrane Glycoproteins--drug effects<br/>N-Glycosyl Hydrolases<br/>Neurons--drug effects<br/>Plant Proteins--administration & dosage<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptor, Nerve Growth Factor<br/>Receptors, Nerve Growth Factor--drug effects<br/>Ribosome Inactivating Proteins, Type 1<br/>Saporins<br/>Septum Pellucidum--drug effects<br/>Substantia Innominata--drug effects